跳至主要内容
临床试验/JPRN-jRCTs032180100
JPRN-jRCTs032180100已完成未知

DLapheresis-mediated Endothelial activation Therapy to Severe-Peripheral Artery Disease study

Toya Yoshiyuki0 个研究点目标入组 35 人开始时间: 2019年1月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 80age old(—)
性别
All

入选标准

  • (1)age between 20 and 80
  • (2)patients diagnosed as peripheral artery disease
  • (3)Fontaine classification >=IIB
  • (4)ankle brachial pressure index <0.7
  • (5)serum total cholesterol<=220mg/dl and LDL cholesterol<=140mg/dl
  • (6)PAD refractory to conventional therapy such as percutaneous transluminal angioplasty or bypass graft surgery
  • (7)PAD resistant to the ameliorations of atherosclerotic risk factors including medication
  • (8)patients with written informed consent

排除标准

  • (1)uncontrolled diabetes despite insulin therapy
  • (2)severe hepatic disorders
  • (3)inevitable use of ACE inhibitors during the treatment period
  • (4)ineligible patients judged by physicians

研究者

发起方
Toya Yoshiyuki

相似试验